Back to competency map

Clinical competency

Communicate risks, benefits, and alternatives

The investigator/therapist has ethical responsibility to explain study goals, course, expected effects, possible advantages and disadvantages, risks, and alternative treatments in verbal and written form. This includes ensuring participant questions are answered satisfactorily and that there is enough time for decision-making.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

1

Courses

0

Providers

0

Protocols

1

Classification

Care stages

Risk monitoring

Protocol families

LSD

Source quality

SOP / guidebook

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (1)

  • Informed Consent / trial document for LDA-1: LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life-threatening diseases

    LSDEvidence score: 70
    Gasser et al., 2014Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth